Westin Copley Place, Boston, MA
Meet us at Booth 212 to learn more about RNAscope™ technology to analyze the tumor microenvironment
Attend the RNAscope™ technology talk during the Immuno-Oncology Targets Session:
State-of-the-Art Tissue Expression Analysis Platform for Multiplexed Immuno-Oncology Target and Biomarker Development
Presenter: Christopher Bunker, PhD, Advanced Cell Diagnostics, Inc.
Wednesday June 14, 5:25 PM
http://www.worldpreclinicalcongress.com/Immuno-Oncology-Targets/#Day2